BIOGEN INC.
Insider Reports History
- Location
- Cambridge, MA
- Signature
- BIOGEN INC. By: /s/ Michael Dambach, Vice President and Treasurer
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by BIOGEN INC.:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SANGAMO THERAPEUTICS, INC | 10%+ Owner | Common Stock | 17,652,466 | $6,745,007 | $0.3821 | 26 Sep 2023 | By Biogen MA Inc. |
| REATA PHARMACEUTICALS INC | Other* | Class A common stock | 0 | $172.03 | 28 Jul 2023 | Indirect |
Insider Reports Filed by BIOGEN INC.
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SGMO | SANGAMO THERAPEUTICS, INC | 26 Sep 2023 | 1 | -$3,000,000 | 4 | 10%+ Owner | 28 Sep 2023, 17:30 |
| /report/000089924323017817-biogen-inc-2023-07-28 | REATA PHARMACEUTICALS INC | 28 Jul 2023 | 0 | $0 | 3 | Other* | 07 Aug 2023, 17:18 |
| SGMO | SANGAMO THERAPEUTICS, INC | 29 Aug 2022 | 2 | -$2,657,240 | 4 | 10%+ Owner | 31 Aug 2022, 19:03 |
| SGMO | SANGAMO THERAPEUTICS, INC | 28 Dec 2021 | 1 | -$23,522 | 4 | 10%+ Owner | 30 Dec 2021, 16:12 |
| SGMO | SANGAMO THERAPEUTICS, INC | 23 Dec 2021 | 2 | -$699,666 | 4 | 10%+ Owner | 28 Dec 2021, 07:11 |
| SGMO | SANGAMO THERAPEUTICS, INC | 09 Dec 2021 | 1 | -$202,541 | 4 | 10%+ Owner | 10 Dec 2021, 15:08 |
| SGMO | SANGAMO THERAPEUTICS, INC | 07 Dec 2021 | 2 | -$1,099,265 | 4 | 10%+ Owner | 09 Dec 2021, 15:08 |
| SGMO | SANGAMO THERAPEUTICS, INC | 01 Dec 2021 | 2 | -$22,166 | 4 | 10%+ Owner | 03 Dec 2021, 15:09 |
| SGMO | SANGAMO THERAPEUTICS, INC | 26 Nov 2021 | 1 | -$248,434 | 4 | 10%+ Owner | 30 Nov 2021, 15:20 |